P. Hammel
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 1
- Hematology top 10%
-
- Cancer Genomics and Diagnostics 2
-
- PARP inhibition in cancer therapy 7
- Pancreatic and Hepatic Oncology Research 4
-
- Economic and Financial Impacts of Cancer 5
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Advanced Breast Cancer Therapies 2
-
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- Beat A. ImhofChristoph UherekDominique DunonRoland H. GislerLuca PialiFelix BachmannDo‐Youn OhTeresa Macarulla
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
P. Hammel
7 papers receiving 347 citations
Peers
Comparison fields: 5 of 57
- Immunology and Allergy 172
- Hematology 80
- Immunology 113
- Cancer Research 50
- Oncology 73
Countries citing papers authored by P. Hammel
This map shows the geographic impact of P. Hammel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hammel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hammel more than expected).
Fields of papers citing papers by P. Hammel
This network shows the impact of papers produced by P. Hammel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hammel. The network helps show where P. Hammel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Hammel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2021 | 0 | |
| 3 | 2020 | 2 | |
| 4 | 2020 | 1 | |
| 5 | 2019 | 33 | |
| 6 | 2019 | 3 | |
| 7 | 2019 | 0 | |
| 8 | 2019 | 1 | |
| 9 | 1995 | 315 |
About P. Hammel
P. Hammel is a scholar working on Oncology, Economics and Econometrics, Immunology and Allergy, Cancer Research and Hematology, having authored 9 papers that have together received 356 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (7 papers), Economic and Financial Impacts of Cancer (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Genomics and Diagnostics (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Cell Adhesion Molecules Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Immunology and Allergy (172 citations), Hematology (80 citations), Immunology (113 citations), Cancer Research (50 citations) and Oncology (73 citations). P. Hammel has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Beat A. Imhof, Christoph Uherek, Dominique Dunon, Roland H. Gisler, Luca Piali, Felix Bachmann, Do‐Youn Oh, Teresa Macarulla, Michele Reni and Dirk Arnold. Their work appears in journals such as Annals of Oncology and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.